Centerpoint Advisors’s Hamilton Lane HLNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13K Sell
162
-1
-0.6% -$89 ﹤0.01% 316
2026
Q1
$16K Hold
163
0.01% 276
2025
Q4
$22K Buy
163
+43
+36% +$5.41K 0.01% 227
2025
Q3
$16K Hold
120
0.01% 292
2025
Q2
$17K Sell
120
-52
-30% -$7.84K 0.01% 277
2025
Q1
$26K Hold
172
0.01% 209
2024
Q4
$25K Sell
172
-26
-13% -$4.63K 0.01% 229
2024
Q3
$33K Hold
198
0.01% 211
2024
Q2
$24K Hold
198
0.01% 234
2024
Q1
$22K Sell
198
-33
-14% -$3.73K 0.01% 233
2023
Q4
$26K Hold
231
0.01% 201
2023
Q3
$21K Sell
231
-1
-0.4% -$89 0.01% 221
2023
Q2
$19K Buy
232
+29
+14% +$2.08K 0.01% 261
2023
Q1
$15K Hold
203
0.01% 309
2022
Q4
$13K Buy
+203
New +$13.5K 0.01% 279

Other funds holding HLNE

Centerpoint Advisors's HLNE Position: Q2 2026 in Review

Centerpoint Advisors reduced its Hamilton Lane (HLNE) stake by 0.61% in Q2 2026, selling an estimated $89 and leaving 162 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #316.

Centerpoint Advisors first reported a position in HLNE in Q4 2022 and has held it in 15 quarters since. The position peaked at $33K in Q3 2024. 381 funds tracked by Wall St. Rank hold HLNE as of Q2 2026.

  • Centerpoint Advisors held 162 shares of Hamilton Lane worth $13K as of Q2 2026.
  • Centerpoint Advisors sold 1 Hamilton Lane share in Q2 2026, an estimated $89.
  • Hamilton Lane made up ﹤0.01% of Centerpoint Advisors's portfolio in Q2 2026, its #316 holding.
  • Centerpoint Advisors first reported a position in Hamilton Lane in Q4 2022 and has held it in 15 quarters since.
  • Centerpoint Advisors's Hamilton Lane position peaked at $33K in Q3 2024.
  • 381 funds tracked by Wall St. Rank held Hamilton Lane as of Q2 2026.

Based on Centerpoint Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.